Skip to content

Serving Veterans, Army, Navy, Marines, Airforce

We Are Proud to Provide Chronic Pain Management to Our Military Personnel

Brian Yanick

Several years ago, Brian underwent a routine heart valve replacement surgery but was unexpectedly faced with a number of complications that caused him to go into a coma for 18 days.

After waking from the coma, Brian found that he lost use of his arm and leg and later diagnosed with CRPS (chronic regional pain syndrome). Watch his testimony above.

 

The Problem

So many of our nation's heroes are suffering from pain both emotionally and physically. 

They have tried everything from physical therapy, controlled diets, prescription drugs, infrared treatments, acupuncture, and homeopathy - yet, nothing seems to work.

They are in pain.
They don't know what to do.
And no one seems to truly understand.

We do - and InterX can help.

Military

Our InterX® products are used by the Navy, Air Force, Army, and Military Medical Centers across the United States.

Benjamin Keizer
My section provides behavioral medicine and pain management services (adjustment to disability, anxiety/depression, insomnia, grief and loss, pain management, PTSD) in a rehabilitation setting for military service members, Veterans, and dependents who sustained serious injuries (e.g., multi‐trauma, burns, critical care, major surgery). I have used the InterX on over one hundred patients since 2014. Although the device works to some degree on numerous pain conditions, I consider it an integral tool for patients who are struggling with severe neuropathic pain conditions like Complex Regional Pain Syndrome and Phantom Limb Pain.
Benjamin Keizer
PhD Psychology Rehabilitation and Psychology Center | Center for the Intrepid | Department of Defense | San Antonio Military Medical Center
★★★★★

In the Clinical Studies section of this website five studies are listed.  All five, in addition to reporting pain reduction, reported reductions in anti-inflammatory medications required. One summary is shown below.

Study Medication
Low Grade Ankle Sprain Etoricoxib 60 mg
Bimalleolar Ankle Fracture Ketorolac
Plantar Fasciitis Etoricoxib 60 mg
TKR Ketorolac
Trochanteric Fracture Ketorolac


TABLE II. The mean (range) post-operative intake of Ketorolac in both groups

Day NIN* Group Sham Group
1 3.47 (3to4) 4.47 (4to5)
2 3.07 (2to4) 4.07 (3to5)
3 2.63 (2to3) 3.77 (3to4)
4 2.03 (1to3) 3.27 (2to4)
5 1.53 (1to2) 2.87 (2to4)
6 1.07 (0to2) 2.57 (2to3)
7 0.73 (0to1) 2.17 (1to3)
8 0.47 (0to1) 1.77 (1to2)
9 0.13 (0to1) 1.33 (1to2)
10 0.00 (0to0) 0.87 (0to1)


*NIN, non-invasive interactive neurostimulation

When pain is reduced, need for pain medications follows.

In a 50-patient study of total knee arthroplasty medication was measured on a morphine equivalence scale, male patients in the active group reduced their pain medication intake by 55% and female patients by 13%.

The Brian Yanik video and Pain Practitioner article, and medical case report all report elimination of opioid medication.  Brian’s medical case history states:


(7 months after patient started InterX)…the pain was well controlled and he was subsequently discharged from the pain clinic. His medication regimen now eliminated opioids and included pregabalin 50 mg twice daily and 100 mg at night. The SM reported continued self-treatment daily with the devices….

 

A study of 22 severe chronic orthopedic patients (no controls) was conducted over a 3-day period with InterX.  15 of the 22 patients experienced a large reduction in pain.


The patients in this study achieved a sustained response that lasted at least 24 hours in between treatments. This was demonstrated by the numeric pain score reductions of AV, PAS and Illicit pre-treatment on Day 2 as compared to pre-treatment Day 1 of 28%, 19% and 18% respective. On Day 3 as compared to Day 2 the pre-treatment scores of AV, PAS, and Illicit improved by an additional 27%, 27% and 23% respectively. These results indicate that, for most patients, the effects of a 30-minute treatment are sustained for at least 24 hours between treatments. The long-term effects and longevity of response need to be further evaluated.

 

Although opioids were not the subject of the study, it was noted that ten patients began the study on significant pain medication (opiates or derivatives and duragesic patches).


Of the group, four patients required duragesic patches. Forty percent (40%) of the patients voluntarily reduced their pain medication requirements (Table 6). Interestingly all of the patients on the duragesic patches voluntarily discontinued the use within the first 24 hours of the study. An additional patient who underwent a shoulder disarticulation, who was semi-lethargic on numerous pain medications, was lucid and had dramatically decreased his pain medication requirement throughout the treatment period.

 

This pilot study is not included in the Clinical Studies section of this website but can be seen here.

Pain Practitioner article, plus his medical case history, are strong.  Here is the conclusion of the Pain Practitioner article:


Our hope is that this case provides preliminary support for the use of Alpha-Stim and InterX for rapid reduction in CRPS severity.

 

Informal support is also given by two video case histories:

 

Linsey Heidelberg video features before, during, and after footage of the InterX treatment, and includes statements by her physician.

 

A recent case involves a teenager who developed CRPS.  The Mayo Clinic diagnosed the CRPS, but did not treat it.

 

In the Clinical Studies section of this website five studies are listed.  All five, in addition to reporting pain reduction, reported reductions in anti-inflammatory medications required. One summary is shown below.

Study Medication
Low Grade Ankle Sprain Etoricoxib 60 mg
Bimalleolar Ankle Fracture Ketorolac
Plantar Fasciitis Etoricoxib 60 mg
TKR Ketorolac
Trochanteric Fracture Ketorolac


TABLE II. The mean (range) post-operative intake of Ketorolac in both groups

Day NIN* Group Sham Group
1 3.47 (3to4) 4.47 (4to5)
2 3.07 (2to4) 4.07 (3to5)
3 2.63 (2to3) 3.77 (3to4)
4 2.03 (1to3) 3.27 (2to4)
5 1.53 (1to2) 2.87 (2to4)
6 1.07 (0to2) 2.57 (2to3)
7 0.73 (0to1) 2.17 (1to3)
8 0.47 (0to1) 1.77 (1to2)
9 0.13 (0to1) 1.33 (1to2)
10 0.00 (0to0) 0.87 (0to1)


*NIN, non-invasive interactive neurostimulation

When pain is reduced, need for pain medications follows.

In a 50-patient study of total knee arthroplasty medication was measured on a morphine equivalence scale, male patients in the active group reduced their pain medication intake by 55% and female patients by 13%.

The Brian Yanik video and Pain Practitioner article, and medical case report all report elimination of opioid medication.  Brian’s medical case history states:


(7 months after patient started InterX)…the pain was well controlled and he was subsequently discharged from the pain clinic. His medication regimen now eliminated opioids and included pregabalin 50 mg twice daily and 100 mg at night. The SM reported continued self-treatment daily with the devices….

 

A study of 22 severe chronic orthopedic patients (no controls) was conducted over a 3-day period with InterX.  15 of the 22 patients experienced a large reduction in pain.


The patients in this study achieved a sustained response that lasted at least 24 hours in between treatments. This was demonstrated by the numeric pain score reductions of AV, PAS and Illicit pre-treatment on Day 2 as compared to pre-treatment Day 1 of 28%, 19% and 18% respective. On Day 3 as compared to Day 2 the pre-treatment scores of AV, PAS, and Illicit improved by an additional 27%, 27% and 23% respectively. These results indicate that, for most patients, the effects of a 30-minute treatment are sustained for at least 24 hours between treatments. The long-term effects and longevity of response need to be further evaluated.

 

Although opioids were not the subject of the study, it was noted that ten patients began the study on significant pain medication (opiates or derivatives and duragesic patches).


Of the group, four patients required duragesic patches. Forty percent (40%) of the patients voluntarily reduced their pain medication requirements (Table 6). Interestingly all of the patients on the duragesic patches voluntarily discontinued the use within the first 24 hours of the study. An additional patient who underwent a shoulder disarticulation, who was semi-lethargic on numerous pain medications, was lucid and had dramatically decreased his pain medication requirement throughout the treatment period.

 

This pilot study is not included in the Clinical Studies section of this website but can be seen here.

Pain Practitioner article, plus his medical case history, are strong.  Here is the conclusion of the Pain Practitioner article:


Our hope is that this case provides preliminary support for the use of Alpha-Stim and InterX for rapid reduction in CRPS severity.

 

Informal support is also given by two video case histories:

 

Linsey Heidelberg video features before, during, and after footage of the InterX treatment, and includes statements by her physician.

 

A recent case involves a teenager who developed CRPS.  The Mayo Clinic diagnosed the CRPS, but did not treat it.

 

Piazza MD
I have had much experience with the InterX units and have advocated their use in 3 other clinics; in some of these locations we maintained over 20 units. I have found them to be invaluable tools both in my role as a primary care physician and as an integrative medicine specialist.
Thomas R. Piazza, MD
Medical Director, Invisible Wounds Initiative
★★★★★

Inflammation, Opioids, and CRPS

The intended use of InterX® products does not currently include these conditions; as a smaller medical device manufacturer, a large study is out of our budget range. Currently we are seeking funding for clinical studies on these medical problems. Below is some evidence that studies are worthwhile.

InterX® Products Are  Available to U.S. Military and Veterans

CONTACT US

 

Clinical Studies

Our work is supported by reviewed and vetted clinical studies. Read the InterX® patients clinical studies, covering a range of topics. You’ll find injury and treated nerve pain case studies, with links to each of the studies full abstracts.

VIEW CLINICAL STUDIES

1A3AB9D7-C17E-4964-B97D-9D1820EB47BB